
Quick Heal Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review
Quick Heal (NSE:QUICKHEAL) CMP: Rs 247.5 (2026). Sector: IT Services. JM Financial: Neutral Rs 295. Kotak Securities: Neutral Rs 270. Consensus: Rs 283. Bull: Rs 295. Bear: Rs 240.
Updated: 18 Jun 2026 • 10:56 am
Posted by:

The Quick Heal stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Quick Heal share price prediction as one data point and not as a guarantee of future performance.
This article reviews every dimension of the Quick Heal stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.
Click Here – Get Free Investment Predictions
What Analysts Predict for Quick Heal Stock in 2026
Analyst consensus on the Quick Heal stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and Kotak Securities. All figures are sourced from publicly available research and should be verified before publishing.
| Brokerage | Rating | Quick Heal Stock Prediction (Rs) | Updated |
|---|---|---|---|
| JM Financial | Neutral | Rs 295 | 2026 |
| Kotak Securities | Neutral | Rs 270 | 2026 |
| Analyst Consensus | – | Rs 283 | 2026 |
The analyst target range for Quick Heal reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Quick Heal stock forecast from the current price of Rs 247.5 may or may not be realised by end of 2026.
3 Stocks Building Serious Momentum Right Now
When Univest analysts identify high-conviction stock opportunities, investors pay attention.
Our research team has shortlisted the Top Stocks to Buy based on current market momentum, sector trends & growth potential for 2026.
- Discover stocks investors are actively accumulating
- High-conviction opportunities backed by research
- Designed for the next phase of market growth
Unlock the latest Top Stock Picks now on Univest
Quick Heal Company Overview
Quick Heal Technologies is one of India's leading technology services companies, serving global clients across banking, manufacturing, retail and healthcare. Its scale makes the Quick Heal stock prediction a benchmark for the Indian IT sector.
| Metric | Value |
|---|---|
| NSE Ticker | QUICKHEAL |
| Sector | IT Services |
| CMP | Rs 247.5 (2026) |
| 52 Week High | – |
| 52 Week Low | – |
| Market Cap | – |
| P/E Ratio | – |
| Quick Heal Stock Prediction Consensus (12M) | Rs 283 |
Quick Heal Stock Prediction by Time Horizon
Analysts split the Quick Heal share price prediction across time frames as near-term drivers differ materially from the long-term view.
Short-Term Quick Heal Stock Prediction
The near-term Quick Heal stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 247.5 are being watched closely. A short-term Quick Heal share price prediction carries the most uncertainty of any time horizon.
12-Month Quick Heal Stock Prediction
JM Financial targets Rs 295 (Neutral) and Kotak Securities targets Rs 270 (Neutral). Most desks refresh their Quick Heal stock forecast within two to four weeks of each quarterly earnings print. The Quick Heal share price prediction should be verified against the most recent analyst reports.
Long-Term Quick Heal Stock Prediction
The long-term outlook for Quick Heal is built on assumptions about demand recovery, margin expansion and revenue diversification in the IT Services sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.
Quick Heal Stock Forecast: Key Factors
The following four factors appear consistently in analyst research on Quick Heal and are the primary inputs into the bull and bear case scenarios.
Deal Wins and Order Book
Large deal wins and total contract value are the primary driver behind the bullish Quick Heal stock prediction from most research desks. A strong order book converts into revenue over 12 to 18 months, giving analysts a basis for the Quick Heal stock forecast. Any slowdown in deal closures would force brokerages to revise the Quick Heal share price prediction.
Operating Margin
Operating margin is central to the Quick Heal stock forecast because margin durability in a soft revenue environment determines how well the Quick Heal share price prediction holds. Analysts tracking the Quick Heal stock prediction closely watch for any dip in EBIT margin.
AI Revenue and Digital Capabilities
The pace of AI revenue growth will be a key variable in the Quick Heal stock prediction. A Quick Heal share price prediction that assumes rapid AI adoption points toward the upper end of the analyst range, while a conservative Quick Heal stock forecast assumes AI projects remain a fraction of revenue.
Dividend and Capital Return
The dividend history forms an income floor that several analysts cite when forming their Quick Heal stock forecast. The dividend component of the Quick Heal share price prediction is more reliable than the price target itself in a volatile market.
Quick Heal Stock Prediction: Bull and Bear Scenarios
| Scenario | Quick Heal Stock Prediction | Key Conditions |
|---|---|---|
| Bull Case | Rs 295 | Strong execution, margin improvement, favourable macro and sector re-rating |
| Base Case | Rs 283 | Steady performance, gradual recovery, margins hold, growth on track |
| Bear Case | Rs 240 | Demand deterioration, margin pressure, sector de-rating and macro headwinds |
The bull case Quick Heal stock forecast of Rs 295 assumes most positive variables converge. The base case of Rs 283 is the analyst consensus and may or may not be achieved.
How Analysts Are Reading the Quick Heal Stock Story
Analyst reviews of the Quick Heal share price prediction highlight the company's core strengths in IT Services alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Quick Heal is built on real business strengths set against real risks.
Key Risks to the Quick Heal Stock Prediction
AI and Technology Disruption
Enterprise AI adoption threatens to automate portions of IT services work. This is the highest-uncertainty variable in any Quick Heal stock prediction, and a structural shift would force analysts to revise the Quick Heal share price prediction significantly.
Weak Discretionary Spending
Enterprise clients continue to defer non-essential IT projects. A prolonged freeze would push the Quick Heal share price prediction toward the lower end of the analyst range and compress the Quick Heal stock forecast.
Currency and Wage Risk
Rupee appreciation against the dollar compresses margins. Wage revisions also affect profitability. Any margin miss linked to currency or wage inflation would trigger downward revisions to the Quick Heal stock forecast.
Competition
Intensifying competition from global peers keeps pressure on pricing. This is a recurring caution in the Quick Heal share price prediction from sell-side desks and embedded in every Quick Heal stock forecast.
How to Monitor the Quick Heal Stock Forecast
Track the Quick Heal share price prediction consensus quarterly. After every earnings release, most brokerages revise their Quick Heal stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Quick Heal is improving or deteriorating.
Compare the current price of Rs 247.5 with the analyst target range of Rs 295 to Rs 270. A wide target band reflects genuine uncertainty on Quick Heal, so position size should reflect that range rather than the midpoint alone.
Review the Quick Heal share price prediction every quarter against key business metrics for the IT Services sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.
Check Live Quick Heal Fundamentals on the Univest Screener
Conclusion
The Quick Heal stock prediction for 2026 reflects the analyst community's assessment of Quick Heal Technologies's competitive position, earnings trajectory and macro environment. JM Financial holds a Neutral stance with a target of Rs 295 while Kotak Securities has a Neutral rating with a target of Rs 270, giving an analyst consensus of Rs 283.
The Quick Heal stock forecast is set against near-term risks that make the Quick Heal share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Quick Heal share price target changes over time is more valuable than relying on any single estimate.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.
Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Quick Heal in real time.
Disclaimer: Data and figures in this article are sourced from publicly available information and may or may not be accurate. Analyst price targets are from public brokerage reports and should be independently verified. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Quick Heal Stock Prediction 2026
What is the Quick Heal stock prediction for 2026?
Ans. The Quick Heal stock prediction for 2026 is based on analyst consensus from JM Financial and Kotak Securities. The consensus target is Rs 283. All estimates may or may not be achieved.
Is the Quick Heal stock prediction bullish or bearish?
Ans. JM Financial has a Neutral rating with target Rs 295. Kotak Securities has a Neutral rating with target Rs 270. The Quick Heal stock forecast reflects genuine analyst diversity of opinion.
What is the Quick Heal share price prediction based on fundamentals?
Ans. The Quick Heal share price prediction rests on the deal win momentum, operating margin, AI revenue trajectory and dividend consistency. Analysts tracking Quick Heal closely cite these as the primary drivers of the 2026 outlook.
What is the long-term Quick Heal stock prediction?
Ans. The long-term outlook assumes Quick Heal sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 283 is the nearest reliable anchor point.
What are the key risks to the Quick Heal stock prediction?
Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Quick Heal should be read alongside its risk assumptions.
What does the Quick Heal stock forecast say for 2026?
Ans. JM Financial: Neutral target Rs 295. Kotak Securities: Neutral target Rs 270. These Quick Heal share price prediction estimates may or may not prove accurate.
Where can I track the latest Quick Heal stock prediction?
Ans. Track the latest analyst targets and price movements for Quick Heal on the NSE and BSE websites and on the Univest app and screener for live data.
Recent Articles

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs UTI Master Equity Plan: NAV, Returns and Maturity Status Compared
28 July 2026

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan IDCW Payout vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: NAV, Returns and Maturity Status Compared
28 July 2026

Reliance Equity Linked Saving Fund - Series I vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
28 July 2026

Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan IDCW Payout vs ICICI Prudential Wealth Enhancement Fund: NAV, Returns and Maturity Status Compared
28 July 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs UTI Master Equity Plan: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan IDCW Payout vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: NAV, Returns and Maturity Status Compared
Reliance Equity Linked Saving Fund - Series I vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan IDCW Payout vs ICICI Prudential Wealth Enhancement Fund: NAV, Returns and Maturity Status Compared
SBI Long Term Advantage Fund - Series VI IDCW vs Bank of India Mid Cap Tax Fund Series 2 Regular Growth: NAV, Returns and Maturity Status Compared
Popular this week
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Regular Plan vs UTI Master Equity Plan: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan IDCW Payout vs Bank of India Mid Cap Tax Fund Series 1 Direct IDCW: NAV, Returns and Maturity Status Compared
Reliance Equity Linked Saving Fund - Series I vs Bank of India Mid Cap Tax Fund Series 1 Regular Growth: NAV, Returns and Maturity Status Compared
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct Plan IDCW Payout vs ICICI Prudential Wealth Enhancement Fund: NAV, Returns and Maturity Status Compared
SBI Long Term Advantage Fund - Series VI IDCW vs Bank of India Mid Cap Tax Fund Series 2 Regular Growth: NAV, Returns and Maturity Status Compared

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





